Skip to main content
[Preprint]. 2020 Jun 22:2020.05.28.20115899. [Version 3] doi: 10.1101/2020.05.28.20115899

Appendix Table D-1.

Correspondence between Garg et al. (2020) and DeCaprio et al. (2020)

Underlying Conditions Garg et al. (2020) Corresponding Condition DeCaprio et al. (2020)
Hypertension Hypertension
Obesity (BMI>=30) Severe Obesity (BMI>=40)
Chronic metabolic disease No exact match (excluded)
 Diabetes mellitus Diabetes
Chronic lung disease
 Asthma Asthma
 Chronic obstructive pulmonary disease (COPD) or emphysema, cystic fibrosis, or chronic bronchitis
Cardiovascular disease (not hypertension)
 Coronary artery disease Rheumatic and other heart disease
 Congestive heart failure Congestive heart failure
Neurologic disease Stroke
Renal disease Chronic kidney disease
Immunosuppressive condition No exact match (excluded)
Gastrointestinal/Liver disease Liver disease
Blood disorder No exact match (excluded)
Rheumatologic/Autoimmune disease
No exact match (excluded)

Notes: Pregnancy is excluded because we do not use it in the PSID estimation. Garg et al. (2020) reports that 30% of obsese patients are severely obese and we apply the percentage uniformly across age groups. We treat all reports of chronic lung disease that are not asthma as being included in COPD, emphysema, cystic fibrosis, or chronic bronchitis. We treat all reports of cardiovascular disease (not hypertension) that are not congestive heart disease as coronary artery disease. We have tested using applying the coefficients for neurocognitive conditions instead of stroke as the corresponding condition for neurologic disease and the results are unchanged. We have also tested using sickle cell/HIV/transplant in DeCaprio et al. (2020) as a match for immunosuppresive conditions in Garg et al. (2020). Again the results are very similar.